| Date Filed | Type | Description |
| 01/11/2023 |
4
| KLOSK STEVEN M (Director) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 01/12/2022 |
4
| KLOSK STEVEN M (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 65,430 shares
@ $0 |
|
| 03/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2020 |
4
| KLOSK STEVEN M (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 18,292 restricted stock units
@ $3.28, valued at
$60k
|
|
| 12/05/2019 |
4
| KLOSK STEVEN M (President & CEO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 65,500 shares
@ $0
Sold 347,206 shares
@ $60, valued at
$20.8M
Exercised 50,000 options to buy
@ $41.36, valued at
$2.1M
Exercised 50,000 options to buy
@ $40.65, valued at
$2M
Exercised 38,000 options to buy
@ $45.64, valued at
$1.7M
Exercised 30,000 options to buy
@ $53.605, valued at
$1.6M
|
|
| 02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/16/2019 |
4
| KLOSK STEVEN M (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 12,121 restricted stock units
@ $4.95, valued at
$60k
|
|
| 01/10/2019 |
4
| KLOSK STEVEN M (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 8,747 shares
@ $0 |
|
| 10/26/2018 |
4
| KLOSK STEVEN M (President & CEO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 30,000 options to buy
@ $53.605, valued at
$1.6M
|
|
| 10/24/2018 |
4
| KLOSK STEVEN M (President & CEO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Sold 16,805 shares
@ $54.6659, valued at
$918.7k
Sold 3,195 shares
@ $55.2718, valued at
$176.6k
Exercised 20,000 options to buy
@ $17.81, valued at
$356.2k
|
|
| 09/05/2018 |
4
| KLOSK STEVEN M (President & CEO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Sold 29,191 shares
@ $65.84, valued at
$1.9M
Sold 25,809 shares
@ $66.83, valued at
$1.7M
Exercised 55,000 options to buy
@ $17.81, valued at
$979.6k
|
|
| 08/07/2018 |
4
| KLOSK STEVEN M (President & CEO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 80,000 shares
@ $0
Sold 53,599 shares
@ $62.07, valued at
$3.3M
Sold 26,401 shares
@ $63.23, valued at
$1.7M
|
|
| 08/02/2018 |
4
| KLOSK STEVEN M (President & CEO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Sold 32,218 shares
@ $62.2331, valued at
$2M
Sold 22,782 shares
@ $62.7786, valued at
$1.4M
Exercised 50,000 options to buy
@ $16.905, valued at
$845.3k
Exercised 5,000 options to buy
@ $17.81, valued at
$89.1k
|
|
| 07/03/2018 |
4
| KLOSK STEVEN M (President & CEO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Sold 30,642 shares
@ $51.45, valued at
$1.6M
Sold 24,358 shares
@ $52.08, valued at
$1.3M
Exercised 25,000 options to buy
@ $12.46, valued at
$311.5k
Exercised 30,000 options to buy
@ $16.905, valued at
$507.2k
|
|
| 06/12/2018 |
4
| KLOSK STEVEN M (President & CEO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Sold 55,000 shares
@ $45.6408, valued at
$2.5M
Exercised 55,000 options to buy
@ $12.46, valued at
$685.3k
|
|
| 01/10/2018 |
4
| KLOSK STEVEN M (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 8,747 restricted stock units
@ $0 |
|
| 11/01/2017 |
4
| KLOSK STEVEN M (President & CEO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 38,000 options to buy
@ $45.635, valued at
$1.7M
|
|
| 10/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2017 |
4
| KLOSK STEVEN M (President & CEO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Sold 5,561 shares
@ $61.0871, valued at
$339.7k
Sold 6,439 shares
@ $61.65, valued at
$397k
Exercised 12,000 options to buy
@ $5.72, valued at
$68.6k
|
|
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/28/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|